# Scarring At Donor Sites After Split-Thickness Skin Graft.

> **NCT04490213** · — · COMPLETED · sponsor: **University Hospital, Linkoeping** · enrollment: 17 (actual)

## Conditions studied

- Donor Site Complication

## Interventions

- **OTHER:** Allevyn, Aquacel and Tegaderm, Mediskin

## Key facts

- **NCT ID:** NCT04490213
- **Lead sponsor:** University Hospital, Linkoeping
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-15
- **Primary completion:** 2019-03-01
- **Final completion:** 2019-03-01
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2020-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04490213

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04490213, "Scarring At Donor Sites After Split-Thickness Skin Graft.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04490213. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*